{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-019156","form_type":"8-K","ticker":null,"cik":"0001564824","company_name":"Allakos Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.803258+00:00","generated_at":"2026-05-21T04:57:52.714157+00:00","sec_items":["2.01","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Allakos acquired by Concentra Biosciences for $0.33/share; delisting from Nasdaq","bullets":["Allakos acquired by Concentra Biosciences via tender offer and merger for $0.33 per share in cash.","Approximately 81.21% of outstanding shares tendered; all conditions satisfied.","Merger completed May 15, 2025; Allakos now a wholly owned subsidiary of Concentra.","Allakos board and officers resigned; replaced by Kevin Tang and other Concentra executives.","Trading of ALLK shares suspended; company to file Form 25 to delist and deregister."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-019156","json":"https://secwatch.observer/filing/0001140361-25-019156.json","markdown":"https://secwatch.observer/filing/0001140361-25-019156.md","text":"https://secwatch.observer/filing/0001140361-25-019156.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/ny20049047x1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:57:52.714157+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"057daf1864","claim":"Robert Alexander resigned as Director at Allakos Inc..","evidence_excerpt":"each of Robert Alexander, Ph.D., Robert E. Andreatta, Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"06cdf4c9b8","claim":"Dolca Thomas resigned as Director at Allakos Inc..","evidence_excerpt":"Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"14d7c6aeb6","claim":"Thomas Wei was appointed as Chief Business Officer at Allakos Inc..","evidence_excerpt":"Thomas Wei, Chief Business Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"},{"claim_id":"1c45b42907","claim":"Paul Walker resigned as Director at Allakos Inc..","evidence_excerpt":"Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3cefb177c4","claim":"Robert Alexander resigned as Officer at Allakos Inc..","evidence_excerpt":"Dr. Alexander, Baird Radford and Adam Tomasi have resigned from their respective positions as officers of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Officer"}],"fact_type":"executive_change"},{"claim_id":"49eb9ff938","claim":"Baird Radford resigned as Officer at Allakos Inc..","evidence_excerpt":"Baird Radford and Adam Tomasi have resigned from their respective positions as officers of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Officer"}],"fact_type":"executive_change"},{"claim_id":"820f99052d","claim":"Amy L. Ladd resigned as Director at Allakos Inc..","evidence_excerpt":"Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8867ea8c0b","claim":"Ryan Cole was appointed as Chief Operating Officer at Allakos Inc..","evidence_excerpt":"Ryan Cole, Chief Operating Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"891c179550","claim":"Michael Hearne was appointed as Chief Financial Officer at Allakos Inc..","evidence_excerpt":"Michael Hearne, Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"935db7b1d5","claim":"Steven P. James resigned as Director at Allakos Inc..","evidence_excerpt":"Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a14785b5a2","claim":"Adam Tomasi resigned as Officer at Allakos Inc..","evidence_excerpt":"Adam Tomasi have resigned from their respective positions as officers of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Officer"}],"fact_type":"executive_change"},{"claim_id":"b8274e187e","claim":"Robert E. Andreatta resigned as Director at Allakos Inc..","evidence_excerpt":"Robert E. Andreatta, Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c46ff3b584","claim":"Kevin Tang was appointed as Director at Allakos Inc..","evidence_excerpt":"The sole director of Merger Sub immediately prior to the Effective Time was Kevin Tang","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cc16d20077","claim":"Kevin Tang was appointed as Chief Executive Officer at Allakos Inc..","evidence_excerpt":"Mr. Tang, Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"e4314d1289","claim":"Stew Kroll was appointed as Chief Development Officer at Allakos Inc..","evidence_excerpt":"Stew Kroll, Chief Development Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Development Officer"}],"fact_type":"executive_change"},{"claim_id":"f9ee3493b0","claim":"Neil Graham resigned as Director at Allakos Inc..","evidence_excerpt":"Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"94ba466adb74aeafbc0bebc153038d94b801583e","claim":"Allakos Inc. underwent a change of control involving Concentra Biosciences, LLC for $0.33 per Share in cash (closed 2025-05-15).","evidence_excerpt":"15, 2025, Merger Sub completed a tender offer to purchase all of the C ompany’s outstanding shares of common stock, par value $0.001 per share (the “ Shares ”), in exchange for $0.33 in cash per Share (the “ Offer Price ”), subject to and in accordance with the terms and conditions set forth in the Offer to Purchase, dated April 15, 2025 (the “ Offer to","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Concentra Biosciences, LLC"},{"label":"Consideration","value":"$0.33 per Share in cash"},{"label":"Closing","value":"2025-05-15"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}